PRL-3, an emerging marker of carcinogenesis, is strongly associated with poor prognosis

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 1, 2011, Pages 99-108

  Guzińska Ustymowicz, Katarzyna ^a   Pryczynicz, Anna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cancer diagnosis and prognosis; Endothelial cells enzymology; Invasion; Messenger RNA analysis; Metastasis; Neoplasms enzymology; Neoplasms genetics; Neoplastic cell expression regulation

Indexed keywords

MESSENGER RNA; PRL 3 PROTEIN; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL MIGRATION; COLORECTAL CARCINOMA; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; METASTASIS; OVARY CARCINOMA; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PRENYLATION; STOMACH CARCINOMA; TUMOR GROWTH;

EID: 79953019177     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152011794941145     Document Type: Article

References (67)

1. Alonso, A.; Sasin, J.; Bottini, N.; Friedberg, I.; Friedberg, I.; Osterman, A.; Godzik, A.; Hunter, T.; Dixon, J.; Mustelin, T. Protein tyrosine phosphatase in the human genome. Cell, 2004, 117(6), 699-711.
2. Zeng, Q.; Hong, W.; Tan, Y.H. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem. Biophys. Res. Commun., 1998, 244(2), 421-727.
3. Matter, W.F.; Estridge, T.; Zhang, C.; Belagaje, R.; Stancato, L.; Dixon, J.; Johnson, B.; Bloem, L.; Pickard, T.; Donaghue, M.; Acton, S.; Jeyaseelan, R.; Kadambi, V.; Vlahos, C.J. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem. Biophys. Res. Commun., 2001, 283(5), 1061-1068.
4. Kim, K.A.; Song, J.S.; Jee, J.; Sheen, M.R.; Lee, C.; Lee, T.G.; Ro, S.; Cho, J.M.; Lee, W.; Yamazaki, T.; Jeon, Y.H.; Cheong C. Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett., 2004, 565(1-3), 181-187.
5. Kozlov, G.; Cheng, J.; Ziomek, E.; Banville, D.; Gehring, K.; Ekiel, I. Structural insights into molecular function of the metastasis- associated phosphatase PRL-3. J. Biol. Chem., 2004, 279(12), 11882-11889.
6. Guo, K.; Li, J.; Tang, J.P.; Koh, V.; Gan, B.Q.; Zeng, Q. Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels. Cancer Biol. Ther., 2004, 3(10), 945-951.
7. Zeng, Q.; Si, X.; Horstmann, H.; Xu, Y.; Hong, W.; Pallen, C.J. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J. Biol. Chem., 2000, 275(28), 21444-21452.
8. Bessette, D.C.; Qiu, D.; Pallen, C.J. PRL PTPs: mediators and markers of cancer progression. Cancer Metastasis Rev., 2008, 27(2), 231-252.
9. Pascaru, M.; Tanase, C.; Vacaru, A.M.; Boeti, P.; Neagu, E.; Popescu, I.; Szedlacsek, S.E. Analysis of molecular determinants of PRL-3. J. Cell. Mol. Med., 2009, 13(9B), 3141-3150.
10. Saha, S.; Bardelli, A.; Buckhaults, P.; Velculescu, V.E.; Rago, C.; St Croix, B.; Romans, K.E.; Choti, M.A.; Lengauer, C.; Kinzler, K.W.; Vogelstein, B. A phosphatase associated with metastasis of colorectal cancer. Science, 2001, 294(5545), 1343-1346.
11. Zeng, Q.; Dong, J.M.; Guo, K.; Li, J.; Tan, H.X.; Koh, V.; Pallen, C.J.; Manser, E.; Hong, W. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res., 2003, 63(11), 2716-2722.
12. Kato, H.; Semba, S.; Miskad, U.A.; Seo, Y.; Kasuga, M.; Yokozaki, H. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin. Cancer Res., 2004, 10(21), 7318-7328.
13. Guo, K.; Li, J.; Wang, H.; Osato, M.; Tang, J.P.; Quah, S.Y.; Gan, B.Q.; Zeng, Q. PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. Cancer Res., 2006, 66(19), 9625-9635.
14. Fiordalisi, J.J.; Keller, P.J.; Cox, A.D. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res., 2006, 66(6), 3153-3161.
15. Forte, E.; Orsatti, L.; Talamo, F.; Barbato, G.; De Francesco, R.; Tomei, L. Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3. Biochim. Biophys. Acta, 2008, 1783(2), 334-344.
16. Khanna, C.; Wan, X.; Bose, S.; Cassaday, R.; Olomu, O.; Mendoza, A.; Yeung, C.; Gorlick, R.; Hewitt, S.M.; Helman, L.J. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat. Med., 2004, 10(2), 182-186.
17. Mizuuchi, E.; Semba, S.; Kodama, Y.; Yokozaki, H. Downmodulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Int. J. Cancer, 2009, 124(8), 1802-1810.
18. Zheng, P.; Liu, Y.X.; Chen, L.; Liu, X.H.; Xiao, Z.Q.; Zhao, L.; Li, G.Q.; Zhou, J.; Ding, Y.Q.; Li, J.M. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer. J. Proteome Res, 2010, 9(10), 4897-4905.
19. Peng, L.; Jin, G.; Wang, L.; Guo, J.; Meng, L.; Shou, C. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3. Biochem. Biophys. Res. Commun., 2006, 342(1), 179-183.
20. Peng, L.; Xing, X.; Li, W.; Qu, L.; Meng, L.; Lian, S.; Jiang, B.; Wu, J.; Shou, C. PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1- ERK1/2 and-MMP2 signaling. Mol. Cancer, 2009, 8, 110.
21. Thiery, J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell. Biol., 2003, 15(6), 740-746.
22. Wang, Y.; Li, Z.F.; He, J.; Li, Y.L.; Zhu, G.B.; Zhang, L.H.; Li, Y.L. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int. J. Colorectal Dis., 2007, 22(10), 1179-1184.
23. Liu, Y.; Zhou, J.; Chen, J.; Gao, W.; Le, Y.; Ding, Y.; Li, J. PRL-3 promotes epithelial mesenchymal transition by regulating cadherin directly. Cancer Biol. Ther., 2009, 8(14), 1352-1359.
24. Basak, S.; Jacobs, S.B.; Krieg, A.J.; Pathak, N.; Zeng, Q.; Kaldis, P.; Giaccia, A.J.; Attardi, L.D. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation. Mol. Cell., 2008, 30(3), 303-314.
25. Min, S.H.; Kim, D.M.; Heo, Y.S.; Kim, H.M.; Kim, I.C.; Yoo, O.J. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2. Life Sci., 2010, 86(1-2), 66-72.
26. Semba, S.; Mizuuchi, E.; Yokozaki, H. Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma. Cancer Sci., 2010, 101(10), 2254-2261.
27. Buffart, T.E.; Coffa, J.; Hermsen, M.A.; Carvalho, B.; van der Sijp, J.R.; Ylstra, B.; Pals, G.; Schouten, J.P.; Meijer, G.A. DNA copy number changes at 8q11-24 in metastasized colorectal cancer. Cell Oncol., 2005, 27(1), 57-65.
28. Bardelli, A.; Saha, S.; Sager, J.A.; Romans, K.E.; Xin, B.; Markowitz, S.D.; Lengauer, C.; Velculescu, V.E.; Kinzler, K.W.; Vogelstein, B. PRL-3 expression in metastatic cancers. Clin. Cancer Res., 2003, 9(15), 5607-5615.
29. Wang, Y.; Li, Z.F.; He, J.; Li, Y. L.; Zhu, G.B.; Zhang, L.H.; Li, Y.L. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int. J. Colorectal Dis., 2007, 22(10), 1179-1184.
30. Zhao, G.P.; Zhou, Z.G.; Lei, W.Z.; Wang, C.; Zheng, X.L.; Zheng, Y.C. Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value. Chin. J. Gastrointestinal Surgery, 2008, 11(5), 487-491.
31. Hatate, K.; Yamashita, K.; Hirai, K.; Kumamoto, H.; Sato, T.; Ozawa, H.; Nakamura, T.; Onozato, W.; Kokuba, Y.; Ihara, A.; Watanabe, M. Liver metastasis of colorectal cancer by proteintyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9. Oncol. Rep., 2008, 20(4), 737-743.
32. Guzinska-Ustymowicz, K.; Pryczynicz, A.; Kemona, A. PTP4A3 expression increases strongly in lymph node metastases from colorectal carcinoma. Anticancer Res., 2009, 29(10), 3913-3916.
33. Peng, L.; Ning, J.; Meng, L.; Shou, C. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. J. Cancer Res. Clin. Oncol., 2004, 130(9), 521-526.
34. Xing, X.; Peng, L.; Qu, L.; Ren, T.; Dong, B.; Su, X.; Shou, C. Prognostic value of PRL-3 overexpression in early stages of colonic cancer. Histopathology, 2009, 54(3), 309-318.
35. Wallin, A.R.; Svanvik, J.; Adell, G.; Sun, X.F. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 2006, 65(2), 452-458.
36. Miskad, U.A.; Semba, S.; Kato, H.; Yokozaki, H. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology, 2004, 71(4), 176-184.
37. Li, Z.R.; Wang, Z.; Zhu, B.H.; He, Y.L.; Peng, J.S.; Cai, S.R.; Ma, J.P.; Zhan, W.H. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Surg. Today, 2007, 37(8), 646-651.
38. Wang, Z.; Cai, S.R.; He, Y.L.; Zhan, W.H.; Chen, C.Q.; Cui, J.; Wu, W.H.; Wu, H.; Song, W.; Zhang, C.H.; Peng, J.J.; Huang, X.H. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Ann. Surg. Oncol., 2009, 16(1), 208-219.
39. Miskad, U.A.; Semba, S.; Kato, H.; Matsukawa, Y.; Kodama, Y.; Mizuuchi, E.; Maeda, N.; Yanagihara, K.; Yokozaki, H. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Virchows Arch., 2007, 450(3), 303-310.
40. Wang, Z.; He, Y.L.; Cai, S.R.; Zhan, W.H.; Li, Z.R.; Zhu, B.H.; Chen, C.Q.; Ma, J.P.; Chen, Z.X.; Li, W.; Zhang, L.J. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference. Int. J. Cancer, 2008, 123(6), 1439-1447.
41. Dai, N.; Lu, A.P.; Shou, C.C.; Li, J.Y. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. World J. Gastroenterol., 2009, 15(12), 1499-1505.
42. Ooki, A.; Yamashita, K.; Kikuchi, S.; Sakuramoto, S.; Katada, N.; Watanabe, M. Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer. Oncol. Rep., 2009, 21(6), 1467-1475.
43. Wang, L.; Peng, L.; Dong, B.; Kong, L.; Meng, L.; Yan, L.; Xie, Y.; Shou, C. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann. Oncol., 2006, 17(10), 1517-1522.
44. Radke, I.; Götte, M.; Kersting, C.; Mattsson, B.; Kiesel, L.; Wülfing, P. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br. J. Cancer, 2006, 95(3), 347-354.
45. Hao, R.T.; Zhang, X.H.; Pan, Y.F.; Liu, H.G.; Xiang, Y.Q.; Wan, L.; Wu, X.L. Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer. J. Cancer Res. Clin. Oncol., 2010, 136(9), 1349-1357.
46. Polato, F.; Codegoni, A.; Fruscio, R.; Perego, P.; Mangioni, C.; Saha, S.; Bardelli, A.; Broggini, M. PRL-3 phosphatase is implicated in ovarian cancer growth. Clin. Cancer Res., 2005, 11(19), 6835-6839.
47. Ren, T.; Jiang, B.; Xing, X.; Dong, B.; Peng, L.; Meng, L.; Xu, H.; Shou, C. Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer. Pathol. Oncol. Res., 2009, 15(4), 555-560.
48. Liu, Y.Q.; Li, H.X.; Lou, X.; Lei, J.Y. Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma. Arch. Pathol. Lab. Med., 2008, 132(8), 1307-1312.
49. Ooki, A.; Yamashita, K.; Kikuchi, S.; Sakuramoto, S.; Katada, N.; Watanabe, M. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma. Int. J. Cancer, 2010, 127(3), 543-554.
50. Ma, Y.; Li, B. Expression of phosphatase of regenerating liver-3 in squamous cell carcinoma of the cervix. Med. Oncol., 2010, DOI 10.1007/s12032-010-9514-3.
51. Zhou, J.; Wang, S.; Lu, J.; Li, J.; Ding, Y. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Int. J. Cancer, 2009, 124(8), 1879-1886.
52. Xu, Y.; Zhu, M.; Zhang, S.; Liu, H.; Li, T.; Qin, C. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. Pathol. Oncol. Res., 2010, 16(2), 169-175.
53. Zhao, W.B.; Li, Y.; Liu, X.; Zhang, L.Y.; Wang, X. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma. Int. J. Mol. Med., 2008, 22(2), 187-192.
54. Yamashita, S.; Masuda, Y.; Matsumoto, K.; Okumura, Y.; Matsuzaki, H.; Kurizaki, T.; Haga, Y.; Katafuchi, S.; Murayama, T.; Ikei, S.; Kawahara, K. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer. Ann. Thorac. Cardiovasc. Surg., 2007, 13(4), 236-239.
55. Ming, J.; Liu, N.; Gu, Y.; Qiu, X.; Wang, E.H. PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer. Pathology, 2009, 41(2), 118-126.
56. Zhang, P.; Zhang, Z.; Li, X.; Lei, J.; Su, K.; Li, X.; Wang, X. Expression and its relationship of PRL-3 and RhoC in non-small cell lung cancer. Chin. J. Lung Cancer, 2010, 13(6), 598-601
57. Kong, L.; Li, Q.; Wang, L.; Liu, Z.; Sun, T. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas. Neuropathology, 2007, 27(6), 516-521.
58. Moon, M.K.; Han, Y.M.; Lee, Y.J; Lee, L.H. Inhibitory activities of anthraquinones from Rubia akane on phosphatase regenerating liver-3. Arch. Pharm. Res., 2010, 33(11), 1747-1751.
59. Heneberg, P. Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs. Curr. Med. Chem., 2009, 16(6), 706-733.
60. Wang, L.; Shen, Y.; Song, R.; Sun, Y.; Xu, J.L.; Xu, Q. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly-metastatic melanoma cells. Mol. Pharmacol., 2009, 76(6), 1238-1245.
61. Park, H.; Jung, S.K.; Jeong, D.G.; Ryu, S.E.; Kim, S.J. Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening. Bioorg. Med. Chem. Lett., 2008, 18(7), 2250-2255.
62. Matsukawa, Y.; Semba, S.; Kato, H.; Koma, Y.; Yanagihara, K.; Yokozaki, H. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo. Pathobiology, 2010, 77(3):155-162.
63. Jiang, Y.; Liu, X.Q.; Rajput, A.; Geng, L.; Ongchin, M.; Zeng, Q.; Taylor, G.S.; Wang, J. Phosphatase PRL-3 is a direct regulatory target of TGF?? in colon cancer metastasis. Cancer Res., 2011, 71(1):234-244.
64. Wang, H.; Vardy, L.A.; Tan, C.P.; Loo, J.M.; Guo, K.; Li, J.; Lim, S.G.; Zhou, J.; Chng, W.J.; Ng, S.B.; Li, H.X.; Zeng, Q. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. Cancer Cell., 2010, 18(1):52-62.
65. Daouti, S.; Li, W.H.; Qian, H.; Huang, K.S.; Holmgren, J.; Levin, W.; Reik, L.; McGady, D.L.; Gillespie, P.; Perrotta, A.; Bian, H.; Reidhaar-Olson, J.F.; Bliss, S.A.; Olivier, A.R.; Sergi, J.A.; Fry, D.; Danho, W.; Ritland, S.; Fotouhi, N.; Heimbrook, D.; Niu, H. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage. Cancer Res., 2008, 68(4), 1162-1169.
66. Guo, K.; Tang, J.P.; Tan, C.P.; Wang, H.; Zeng, Q. Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice. Cancer Biol. Ther., 2008, 7(5), 750-757.
67. P. Rising of Phosphatases as Targets of Cancer Treatment. Anticancer Agents Med. Chem., 2011, 11:in press.